COVID-19 in Nursing Homes 2020 and 2021
- Conditions
- Comorbidities and Coexisting ConditionsFrailtyCovid19
- Registration Number
- NCT04945863
- Lead Sponsor
- Lena Nilsson
- Brief Summary
To describe the effect on mortality in nursing home facilities during three separate equally long periods during the pandemic and more specifically to analyse the effect on mortality of improved preventive routines and vaccination.
- Detailed Description
Retrospective descriptive cohort study in Östergötland County Council, Sweden comprising 136 nursing home facilities with a possibility to host 4500 residents. All residents in any of these NHs who had a laboratory confirmed COVID-19 diagnosis between March 2020 to April 2021 and who died within 30 days after the verified diagnosis are included. The study is undertaken as a retrospective record review. From the records patient-level data on demographic variables, clinical signs, comorbidity, performance status, and cause of death are collected.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 258
- All residents in any of 136 nursing homes in Östergötland County Council, Sweden who had a laboratory confirmed COVID-19 diagnosis and who died within 30 days after the verified COVID-19 were included in three separate periods: First period from March 31 to June 30 2020; second period from October 15 2020 to January 15 2021; third period from January 16 to April 18 2021.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comorbidity March 2020 to April 2021 Number of diagnoses bedisde COVID-19
Cause of death March 2020 to April 2021 assessment of cause of death
Frailty March 2020 to April 2021 The combined assessment of performance status and frailty was adapted to the record review method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Anestesi- och operationskliniken, Universitetssjukhuset
🇸🇪Linköping, Sweden